Namibia Registers Twice-a-Year HIV Prevention Drug

Namibia Registers Twice-a-Year HIV Prevention Drug

The Ministry of Health and Social Services has registered lenacapavir, a long-acting HIV prevention medication administered twice a year, as part of efforts to strengthen the country's HIV prevention response.

Lenacapavir gets green light in Namibia – Windhoek Observer

Justicia Shipena The Ministry of Health and Social Services has approved the registration of lenacapavir. Lenacapavir is a long-acting HIV prevention medicine administered twice a year. Lenacapavir is used as pre-exposure prophylaxis (PrEP) and is given as an injectable formulation.  This differs from existing PrEP options, which require people to take tablets every day. Thousands of Namibians are currently using daily oral PrEP. Namibia has sur…